Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications.
It means the public is interested in supporting public health and disease detection, helping us react faster to incoming disease threats," Heather Reese said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results